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SCIENTIFIC OPINION 
Scientific Opinion on the substantiation of health claims related to: dairy 
products (ID 1140, 1141, 1191), raw or processed food products of animal 
origin, plus bread and panification products (ID 1193, 1194), herbal yeast 
plasmolysate (ID 1815, 1816), apple polyphenols (ID 2713), rye flour 
(ID 1266), tomato juice (ID 1202), whey protein and alphalactalbumin 
(ID 424, 430, 432, 725, 1433), “brocco shoots”, “broccoli sprout powder” 
and “Brassica oleracea var. italica (broccoli)” (ID 1362, 1481, 2844, 2845), 
honey (ID 1159, 1160, 1318, 4678, 4679), and Cucurbita pepo L. (pumpkin) 
seeds and seed extracts (ID 2029, 2365) pursuant to Article 13(1) of 
Regulation (EC) No 1924/2006
1
 
EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)
2,
 
3
 
European Food Safety Authority (EFSA), Parma, Italy 
SUMMARY 
Following a request from the European Commission, the Panel on Dietetic Products, Nutrition and 
Allergies was asked to provide a scientific opinion on a list of health claims pursuant to Article 13 of 
                                                     
1  On request from the European Commission, Question No EFSA-Q-2008-1211, EFSA-Q-2008-1217, EFSA-Q-2008-1219, 
EFSA-Q-2008-1512, EFSA-Q-2008-1879, EFSA-Q-2008-1880, EFSA-Q-2008-1898, EFSA-Q-2008-1899, EFSA-Q-
2008-1930, EFSA-Q-2008-1932, EFSA-Q-2008-1933, EFSA-Q-2008-1941, EFSA-Q-2008-2004, EFSA-Q-2008-2055, 
EFSA-Q-2008-2099, EFSA-Q-2008-2170, EFSA-Q-2008-2218, EFSA-Q-2008-2548, EFSA-Q-2008-2549, EFSA-Q-
2008-2762, EFSA-Q-2008-3098, EFSA-Q-2008-3446, EFSA-Q-2008-3577, EFSA-Q-2008-3578, EFSA-Q-2010-00631, 
EFSA-Q-2010-00632, adopted on 25 March 2011. 
2  Panel members: Carlo Agostoni, Jean-Louis Bresson, Susan Fairweather-Tait, Albert Flynn, Ines Golly, Hannu Korhonen, 
Pagona Lagiou, Martinus Løvik, Rosangela Marchelli, Ambroise Martin, Bevan Moseley, Monika Neuhäuser-Berthold, 
Hildegard Przyrembel, Seppo Salminen, Yolanda Sanz, Sean (J.J.) Strain, Stephan Strobel, Inge Tetens, Daniel Tomé, 
Hendrik van Loveren and Hans Verhagen. Correspondence: nda@efsa.europa.eu 
3  Acknowledgement: The Panel wishes to thank for the preparatory work on this scientific opinion: The members of the 
Working Group on Claims: Carlo Agostoni, Jean-Louis Bresson, Susan Fairweather-Tait, Albert Flynn, Ines Golly, Marina 
Heinonen, Hannu Korhonen, Martinus Løvik, Ambroise Martin, Hildegard Przyrembel, Seppo Salminen, Yolanda Sanz, 
Sean (J.J.) Strain, Inge Tetens, Hendrik van Loveren and Hans Verhagen. The members of the Claims Sub-Working Group 
on Gut/Immune: Jean-Louis Bresson, Maria Carmen Collado, Miguel Gueimonde, Daisy Jonkers, Martinus Løvik, Bevan 
Moseley, Maria Saarela, Seppo Salminen, Yolanda Sanz, Stephan Strobel, Daniel Tomé and Hendrik van Loveren. The 
members of the Claims Sub-Working Group on Cardiovascular Health/Oxidative Stress: Antti Aro, Marianne Geleijnse, 
Marina Heinonen, Ambroise Martin, Wilhelm Stahl and Henk van den Berg. The members of the Claims Sub-Working 
Group on Weight Management/Satiety/Glucose and Insulin Control/Physical Performance: Kees de Graaf, Joanne Harrold, 
Mette Hansen, Mette Kristensen, Anders Sjödin and Inge Tetens. The members of the Claims Sub-Working Group on 
Mental/Nervous System: Jacques Rigo, Astrid Schloerscheidt, Barbara Stewart-Knox, Sean (J.J.) Strain, and Peter Willatts. 
 
Health claims related to not sufficiently characterised foods/food constituents   
 
2 EFSA Journal 2011;9(6):2243 
Regulation (EC) No 1924/2006. This opinion addresses the scientific substantiation of health claims 
in relation to: dairy products; raw or processed food products of animal origin, plus bread and 
panification products; herbal yeast plasmolysate; apple polyphenols; rye flour; tomato juice; whey 
protein and alphalactalbumin; “brocco shoots”, “broccoli sprout powder” and “Brassica oleracea var. 
italica (broccoli)”; honey; and Cucurbita pepo L. (pumpkin) seeds and seed extracts. The scientific 
substantiation is based on the information provided by the Member States in the consolidated list of 
Article 13 health claims and references that EFSA has received from Member States or directly from 
stakeholders. 
The foods/food constituents that are the subject of this opinion are: 
 Dairy products related to the following claimed effects: weight management and maintenance of 
tooth mineralisation (ID 1140, 1141, 1191). 
 Raw or processed food products of animal origin, plus bread and panification products related to 
the following claimed effects: maintenance of blood cholesterol concentrations and blood glucose 
control (ID 1193, 1194). 
 Herbal yeast plasmolysate related to the following claimed effects: physical performance and 
concentration (ID 1815, 1816). 
 Apple polyphenols related to the following claimed effect: blood glucose control (ID 2713). 
 Rye flour related to the following claimed effect: low glycaemic index (ID 1266). 
 Tomato juice related to the following claimed effect: blood glucose control (ID 1202).  
 Whey protein and alphalactalbumin related to the following claimed effects: immune defence 
against pathogens, cognitive function, mood, and blood pressure (ID 424, 430, 432, 725, 1433). 
 “Brocco shoots”, “broccoli sprout powder” and “Brassica oleracea var. italica (broccoli)” related 
to the following claimed effect: protection of cells and molecules, including cells of the immune 
system, against oxidative damage (ID 1362, 1481, 2844, 2845). 
 Honey related to the following claimed effects: protection of cells and molecules from oxidative 
damage, defence against pathogens, and maintenance of blood cholesterol concentrations 
(ID 1159, 1160, 1318, 4678, 4679). 
 Cucurbita pepo L. (pumpkin) seeds and seed extracts related to the following claimed effect: 
maintenance of normal prostate size and normal urination (ID 2029, 2365). 
The information given in the consolidated list and in the references provided did not allow the Panel 
to sufficiently characterise the foods/food constituents which are the subject of this opinion. 
The Panel considers that the foods/food constituents which are the subject of this opinion are not 
sufficiently characterised, or are not sufficiently characterised in relation to the proposed claimed 
effects. 
On the basis of the data presented, the Panel concludes that a cause and effect relationship cannot be 
established between the foods/food constituents which are the subject of this opinion and the claimed 
effects. 
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INFORMATION AS PROVIDED IN THE CONSOLIDATED LIST 
The consolidated list of health claims pursuant to Article 13 of Regulation (EC) No 1924/2006
4
 
submitted by Member States contains main entry claims with corresponding conditions of use and 
literature for similar health claims. EFSA has screened all health claims contained in the original 
consolidated list of Article 13 health claims which was received by EFSA in 2008 using six criteria 
established by the NDA Panel to identify claims for which EFSA considered sufficient information 
had been provided for evaluation and those for which more information or clarification was needed 
before evaluation could be carried out
5
. The clarifications which were received by EFSA through the 
screening process have been included in the consolidated list. This additional information will serve 
as clarification to the originally provided information. The information provided in the consolidated 
list for the health claims which are the subject of this opinion is tabulated in Appendix C.  
ASSESSMENT 
The approach used in the evaluation of Article 13(1) health claims is explained in the general 
guidance for stakeholders on the evaluation of Article 13.1, 13.5 and 14 health claims
6
.  
In assessing each specific food/health relationship that forms the basis of a health claim the NDA 
Panel considers the extent to which:   
1. the food/constituent is defined and characterised;  
2. the claimed effect is defined and is a beneficial physiological effect (“beneficial to human health”);   
3. a cause and effect relationship is established between the consumption of the food/constituent and 
the claimed effect (for the target group under the proposed conditions of use).  
Substantiation of the claim is dependent on a favourable outcome of the assessment of 1, 2 and 3 
above. Thus, a cause and effect relationship is considered not to be established if the outcome of any 
one of these assessments is unfavourable.  
For a claim, each relationship between a food/constituent and a claimed effect is assessed separately, 
and individual assessments are combined, as appropriate, to form coherent opinions. 
1. Characterisation of the food/constituent  
1.1. Dairy products (ID 1140, 1141, 1191)  
The food that is the subject of the claim is: “dairy (low fat dairy), dairy refers to cow’s milk, yogurt 
and cheese)”, “(cow’s) milk and dairy products for which milk is the principle ingredient and no sugar 
has been added – e.g. yogurt, cheese”, and “fat free dairy products with reduced sugars or without 
added sugars” related to the following claimed effects: weight management and maintenance of tooth 
mineralisation. 
From the information provided, the Panel assumes that the food refers to dairy products (milk, yogurt 
and cheese) from cow’s milk which are low in fat or fat free with no added sugars. The Panel notes 
                                                     
4  Regulation (EC) No 1924/2006 of the European Parliament and of the Council of 20 December 2006 on nutrition and 
health claims made on foods. OJ L 404, 30.12.2006, p. 9–25.  
5  EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA), 2011. General guidance for stakeholders on the 
evaluation of Article 13.1, 13.5 and 14 health claims. EFSA Journal, 9(4):2135, 24 pp. 
6 See footnote 5 
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that dairy products include solid, semi-solid and liquid food products with different energy density, 
and that no information has been provided with respect to other nutritional characteristics (e.g. protein 
content, and added fibre) which could have an effect on body weight. The Panel also notes that 
lactose, the content of which may vary widely from one dairy product to another, is fermented by oral 
bacteria, and that the effect of different dairy products on tooth mineralisation may vary depending on 
whether they are chewed (e.g. cheese) or not, and on the frequency of consumption.  
The Panel considers that the food category, dairy products, which is the subject of the health claims, 
is not sufficiently characterised in relation to the claimed effects considered in this section. 
The Panel concludes that a cause and effect relationship cannot be established between the 
consumption of dairy products and the claimed effects considered in this section. 
1.2. Raw or processed food products of animal origin, plus bread and panification products 
(ID 1193, 1194) 
The food that is the subject of the health claims is “raw or processed food products of animal origin, 
plus bread and panification products” related to the following claimed effects: maintenance of blood 
cholesterol concentrations and blood glucose control. 
The information provided in relation to these claims defines these foods as “rich in omega 3”. 
However, the Panel notes that the energy density, fatty acid profile, and the nature and amount of 
carbohydrates contained in these foods, all of which could have an impact on the claimed effects, are 
not specified and may be highly variable from one food product to another.  
The Panel considers that the foods, “raw or processed food products of animal origin, plus bread and 
panification products”, which are the subject of the claim, are not sufficiently characterised in relation 
to the claimed effects considered in this section. 
The Panel concludes that a cause and effect relationship cannot be established between the 
consumption of “raw or processed food products of animal origin, plus bread and panification 
products” and the claimed effects considered in this section. 
1.3. Herbal yeast plasmolysate (ID 1815, 1816) 
The food constituent that is the subject of the health claims is “herbal yeast plasmolysate 
(Saccharomyces cerevisiae)” related to the following claimed effects: physical performance and 
concentration. 
In the context of the references provided, the Panel assumes that the claim refers to a specific 
commercial preparation of herbal yeast plasmolysate where Saccharomyces cerevisiae Meyen (not 
further specified) is cultivated in a medium containing specific but unidentified plant extracts, and is 
washed and subjected to plasmolysis by fermentation. Saccharomyces cerevisiae Meyen refers to a 
group of yeast strains that were re-classified by taxonomists (Molina et al., 1992). 
The Panel notes that neither the identity of the yeast strain nor the composition of the plant extract in 
which the yeast is cultivated have been provided. The Panel also notes that no studies on the 
consumption of herbal yeast plasmolysate in relation to the claimed effects were available, and 
therefore the food constituents in herbal yeast plasmolysate which could be relevant for the claimed 
effects are unclear. 
The Panel considers that the food, herbal yeast plasmolysate, which is the subject of the claim, is not 
sufficiently characterised in relation to the claimed effects considered in this section. 
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The Panel concludes that a cause and effect relationship cannot be established between the 
consumption of herbal yeast plasmolysate and the claimed effects considered in this section. 
1.4. Apple polyphenols (ID 2713) 
The food constituent that is the subject of the health claim is “Pyrus malus (common name apple) 
extract powder containing polyphenols” related to the following claimed effect: post-prandial 
glycaemic responses. 
Polyphenols include a wide range (thousands) of compounds belonging to subgroups of flavanones, 
flavonols, flavan-3-ols, such as proanthocyanidins, as well as flavonones, isoflavonoids and 
anthocyanins. Apples typically contain hydroxycinnamic acid derivatives, flavan-3-ols (monomeric 
and oligomeric), flavonols and their conjugates, and dihydrochalcones such as phlorizin (Shahidi and 
Naczk, 2004). In addition, anthocyanins are found in the skin of some red apple varieties.  
The Panel notes that the nature and amount of different polyphenol compounds in the apple extract 
powder has not been specified in the information provided.  
Two of the three references provided for the scientific substantiation of the claim were a narrative 
review on the health effects of phlorizin, which included no original data, and one unpublished in 
vitro study for which only an abstract was available. The third reference reported on a human 
intervention study on the effects of clear and cloudy apple juices characterised on the basis of their 
content in single polyphenols (e.g. phlorizin, chlorogenic acids, phloretin xyloglucoside and 
(+)-catechin) and sugars on post-prandial glycaemic and insulinaemic responses as compared to a 
control beverage containing the same amount of sugars (Johnston et al., 2002). The Panel notes that 
the pectin content in the apple juices is not reported, and that therefore none of them are sufficiently 
characterised with respect to all of the components which could have an impact on the claimed effect 
(EFSA Panel on Dietetic Products Nutrition and Allergies (NDA), 2010). 
The Panel considers that the food constituent, apple polyphenols, which is the subject of the claim, is 
not sufficiently characterised in relation to the claimed effect considered in this section. 
The Panel concludes that a cause and effect relationship cannot be established between the 
consumption of apple polyphenols and the claimed effect considered in this section. 
1.5. Rye flour (ID 1266) 
The food constituent that is the subject of the health claims is rye flour related to the following 
claimed effect: low glycaemic index.  
Rye flour is obtained through milling of rye (Secale cereale L.) grain. Rye flour is typically used to 
prepare rye bread and sourdough bread, and other products that are generally darker and denser than 
other types of similar products made from wheat. The milling of rye results in rye flour of different 
extraction rates varying from around 65 to 100 % (whole grain).  
The chemical composition of rye flour varies considerably with the extraction rate, and thus with the 
degree of milling. As the milling process advances, progressive decreases in starch, β-glucans 
(indicator of rye bran) and moisture content, as well as increase in protein content, are observed 
(Gómez et al., 2009). The content of rye dietary fibre with arabinoxylan as the dominating fibre 
component varies considerably with the milling, and with both the genotype and the environment 
(Hansen et al., 2004). A variety of specific and non-specific methods for the analysis of various 
carbohydrate fractions in rye flour is available. Nutritionally, it is important to differentiate between 
two broad categories of carbohydrates: those digested and absorbed in the human small intestine 
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providing carbohydrates to body cells (commonly referred to as digestible, available or glycaemic 
carbohydrates), and those passing to the large intestine forming substrate for the colonic microflora 
(commonly referred to as nondigestible, “unavailable” or non-glycaemic carbohydrates). 
The claimed effect is a low glycaemic index. The concept of glycaemic index (GI) was originally 
introduced to classify carbohydrate-rich foods (usually having an energy content of >80 % from 
carbohydrates), according to the differences in effects on post-meal glycaemia (Brouns et al., 2005). 
The GI, which is a nutritional property of a carbohydrate-rich food, is defined as the incremental area 
under the blood glucose response curve following a 50 g glycaemic carbohydrate portion of a test 
food expressed as a percentage of the response to the same amount of carbohydrates from a standard 
reference product taken by the same subject (FAO/WHO, 1998). Carbohydrate-rich foods can be 
classified according to their GI values (glucose as the standard): high GI>70; normal GI 55-70; 
low GI 40-55 and very low<40) (Brand-Miller, 2003). However, the GI of a carbohydrate-containing 
food depends on several factors (e.g. amount and type of dietary fibre, amount of dietary fat, energy 
density, physical properties, and mode of preparation) other than the amount of available (glycaemic) 
carbohydrates present.  
Taking into account that the chemical nature and processing of the rye flour, which is the subject of 
the claim, has not been defined, that the GI of rye flour and food products made from rye flour 
depends on the chemical and physical properties, and preparation, of the particular type of rye flour 
under consideration, and that low GI carbohydrates have not been defined in the information 
provided, the Panel considers that the food constituent, rye flour, which is the subject of the health 
claim, is not sufficiently characterised in relation to the claimed effect considered in this section. 
The Panel concludes that a cause and effect relationship cannot be established between the 
consumption of rye flour and the claimed effect considered in this section. 
1.6. Tomato juice (ID 1202) 
The food that is the subject of the health claim is tomato juice related to the following claimed effect: 
blood glucose control.  
From the conditions of use and the only reference provided no information on the composition and/or 
manufacturing process of the tomato juice which is the subject of the health claim was provided. 
The Panel considers that the food, tomato juice, which is the subject of the claim, is not sufficiently 
characterised. 
The Panel concludes that a cause and effect relationship cannot be established between the 
consumption of tomato juice and the claimed effect considered in this section. 
1.7. Whey protein and alphalactalbumin (ID 424, 430, 432, 725, 1433) 
The food constituents that are the subject of the health claims are whey protein and alphalactalbumin 
related to the following claimed effects: immune defence against pathogens, cognitive function, 
mood, and blood pressure. 
Whey protein is a mixture of globular proteins isolated from whey, a by-product obtained during the 
manufacturing of cheese from cow’s milk. Beta-lactoglobulin (approximately 50 %), 
alpha-lactalbumin (approximately 20 %), bovine serum albumin (approximately 10 %) and 
immunoglobulins are the major protein fractions in whey. The composition and amino acid profile of 
whey protein preparations may vary depending on the enrichment of one of these fractions, such as 
alpha-lactalbumin (Markus et al., 2002). Whey can be treated and processed in different ways 
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depending on the type of whey protein and products to be obtained. The main commercial forms are 
concentrates (29-89 % protein by weight), isolates (about 90 % protein by weight) and hydrolysates 
(partially pre-digested). Differences in composition between different whey protein products may 
exist depending on the manufacturing processes applied (Onwulata et al., 2004). The products 
generally have a high content of essential amino acids, with especially high proportions of available 
lysine, cysteine and tryptophan. Whey protein composition also differs between breeds of cow (Haug 
et al., 2007; Meisel and FitzGerald, 2003). 
In relation to ID 430, 432 and 1433, the Panel notes that the composition of whey protein is variable, 
especially with regard to constituents such as alpha-lactalbumin, which is claimed to have 
psychoactive properties. Alpha-lactalbumin is a protein which occurs naturally in mammalian milk, 
and is measurable in foods by established methods. Alpha-lactalbumin is composed of 123 amino 
acids, including tryptophan which is a precursor of the neurotransmitter serotonin. The tryptophan 
content of alpha-lactalbumin preparations is variable, and can range from 1.2 g/100 g (Markus et al., 
2002; Merens et al., 2005) to 4.8 g/100 g (Markus et al., 2005). The Panel notes that the references 
provided for these IDs refer to different food products containing various commercial whey protein or 
alpha-lactalbumin preparations, and that the composition of these food products is variable, in 
particular with respect to their amino acid profile, which may have an impact on the claimed effects. 
The Panel notes that from the information provided it is not possible to determine the food 
constituent(s) which are the subject of the claims. 
In relation to ID 725, the Panel notes that from the conditions of use and references provided it is not 
possible to determine the particular whey protein peptides which are the subject of the claim. 
In relation to ID 424, the Panel notes that in the references provided different commercial whey 
protein products were used, and that no information has been given on the composition, or on the 
standardisation of the manufacturing process, of these products. The Panel notes that from the 
information provided it was not possible to determine the specific “whey protein” product which is 
the subject of the claim. 
The Panel considers that the food constituents, whey protein and alphalactalbumin, which are the 
subject of the claim, are not sufficiently characterised in relation to the claimed effects considered in 
this section. 
The Panel concludes that a cause and effect relationship cannot be established between the 
consumption of whey protein and alphalactalbumin and the claimed effects considered in this section. 
1.8. “Brocco shoots”, “broccoli sprout powder” and “Brassica oleracea var. italica 
(broccoli)” (ID 1362, 1481, 2844, 2845)  
The foods that are the subject of the health claims are “brocco shoots”, “broccoli sprout powder” and 
“Brassica oleracea var. italica (broccoli)” related to the following claimed effect protection of cells 
and molecules, including cells of the immune system, from oxidative damage. 
Broccoli is the common name of the Italica cultivar group of the Brassica oleracea species in the 
Brassicaceae (belonging to Cruciferae) family, whose large flower head is used as a vegetable. 
Broccoli sprouts are 3-4 day old broccoli plants. Different varieties of Brassica oleracea Italica (e.g. 
sprouting broccoli, purple cauliflower, orange cauliflower and green cauliflower), some of which are 
produced by selective breeding, are available on the market. 
The nutritional composition of broccoli flowers and sprouts depends on a variety of factors, including 
climate, season, horticultural practices, and the variety and age of the plant.  
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The Panel notes that for ID 2845 the conditions of use refer to sulphoraphane, but no references on 
sulphoraphane in broccoli have been provided in relation to the claimed effect. The Panel also notes 
that ID 2844 and 2845 specify in the conditions of use “broccoli seed or sprout or vegetable extract 
equivalent to 30 mg of glucoraphanin per day”. Glucoraphanin is a glucosinolate found in vegetables 
of the Brassicaceae family which can be hydrolysed to the isothiocyanate sulforaphane.  
The vast majority of the references provided for the scientific substantiation of these claims were 
animal and in vitro studies which addressed the effects of glucosinolates (including glucoraphanin) or 
its isothiocyanate metabolites, sulforaphane, (and its N-acetylcysteine conjugates), sulforaphane 
nitrile and/or phenethyl-, allyl- or benzyl-isothiocyanate on cancer-related outcomes which are 
unrelated to the claimed effects considered in this section, or addressed the composition of different 
cruciferous vegetables in relation to these compounds. The few human studies provided (mostly 
epidemiological observations) investigated the association between consumption of cruciferous 
vegetables (including broccoli) and the urinary excretion of isothiocyanates and cancer-related 
outcomes. One human intervention study on the acute effects of one-week consumption of broccoli 
sprouts, for which no characterisation was available, on markers of oxidative stress (Murashima et al., 
2004), and one human intervention study on the effects of 4-week consumption of Brassica 
vegetables in general on markers of oxidative stress were also provided. From the information 
provided in relation to the claims evaluated in this section, the foods which are the subject of the 
claim were not sufficiently characterised in relation to the claimed effect. 
The Panel considers that the foods, “brocco shoots”, “broccoli sprout powder” and “Brassica 
oleracea var. italica (broccoli)”, which are the subject of the claims, are not sufficiently characterised 
in relation to the claimed effects considered in this section. 
The Panel concludes that a cause and effect relationship cannot be established between the 
consumption of “brocco shoots”, “broccoli sprout powder” and “Brassica oleracea var. italica 
(broccoli)” and the claimed effects considered in this section. 
1.9. Honey (ID 1159, 1160, 1318, 4678, 4679) 
The food that is the subject of the health claims is honey related to the following claimed effects: 
protection of cells and molecules from oxidative damage, defence against pathogens, and maintenance 
of blood cholesterol concentrations. 
Honey is a sweet food made by honey bees (genus Apis, many subspecies); less common is honey 
made by non-stinging bees. Honey is usually made from the nectar (sugar-rich secretions) of flowers 
by a process of regurgitation, and can be monofloral, polyfloral, or blended; there are regional honeys, 
and classifications according to processing, colour and optical density. Honey can also be made from 
honeydew (sweet secretions from aphids and some scale insects). 
According to Council Directive 2001/110/EC
7
 and the Codex Standard for honey (Codex 
Alimentarius, 1981), honey is defined as “the natural sweet substance produced by bees from the 
nectar of plants or from secretions of living parts of plants or excretions of plant-sucking insects on 
the living parts of plants, which the bees collect, transform by combining with specific substances of 
their own, deposit, dehydrate, store and leave in honeycombs to ripen and mature”. 
About 95 % of honey dry matter is composed of carbohydrates, mainly fructose and glucose but also 
around 25 different oligosaccharides. Different types of honey induce variable glycaemic responses, 
reflecting the differences in composition and botanical source. Honey contains small amounts of 
proteins, enzymes, amino acids, minerals and trace elements, vitamins, aroma compounds and 
                                                     
7 Council Directive 2001/110/EC of 20 December 2001 relating to honey. OJ L 10, 12.1.2002, p. 47-52. 
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polyphenols. Compositional criteria include the sugar content, moisture content, water-insoluble solid 
content, electrical conductivity, free acids, diastase activity and hydroxymethyfurfural (HMF) content. 
Composition varies substantially depending on the floral source and geographical location (Bogdanov 
et al., 2008).  
For ID 1160, fructooligosaccharides (FOS) and “antioxidant phytochemicals” present in honey were 
specified as “active” substances. FOS in honey differ in composition as well as in degree of 
polymerisation. FOS content in honey is variable and is dependent on the floral source of the honey. 
The references cited did not specify the composition or the content of these substances.  
The Panel notes that according to the references provided the composition of honey is variable and 
depends on the floral origin, the geographic location, the season and the processing conditions, that 
honeys produced in different regions were mentioned, and that it was not possible to characterise the 
specific honey for which the claims are made.  
The Panel considers that the food, honey, which is the subject of the health claims, is not sufficiently 
characterised in relation to the claimed effects considered in this section. 
The Panel concludes that a cause and effect relationship cannot be established between the 
consumption of honey and the claimed effects considered in this section. 
1.10. Cucurbita pepo L. (pumpkin) seeds and seed extracts (ID 2029, 2365) 
The food that is the subject of the health claims is Cucurbita pepo L. (pumpkin) seeds and seed 
extracts related to the following claimed effects: maintenance of normal prostate size and normal 
urination. 
The pumpkin (Cucurbita pepo L.) is native to America, but is cultivated worldwide in warm and 
temperate regions. Pumpkin seeds are small, rather flat and oval-shaped, sometimes white but usually 
vibrant orange. Hull-less seeds contain 41 to 59 wt% fat, approximately 35 wt% protein, with albumin 
and globulin being the most prominent proteins, 5 to 7 wt% water, and minor amounts of 
carbohydrates, fibre and ash (Fruhwirt and Hermetter, 2007). Pumpkin seeds also contain a variety of 
phytosterols, minerals and carotenoids. Because of the wide variety of pumpkin species, the fatty acid 
composition of the oil obtained from them can vary significantly. The fatty acid pattern of Cucurbita 
pepo subsp. pepo var. styriaca, a variety which is used by some manufacturers as a source for 
pumpkin seed oil or pumpkin seed extracts, has been provided. Various pumpkin seed compounds 
(phytosterols, fatty acids, minerals and vitamins) have been postulated to have an effect on 
maintenance of normal prostate size and normal urination in males.  
Two human studies were conducted with a specific preparation of pumpkin seeds, which contained 
500 mg of a (15-25:1) pumpkin seed extract derived from a 92 % alcohol extraction of seeds from 
Cucurbita pepo subsp. pepo var. styriaca (Bach, 2000; Friederich et al., 2000). No compositional data 
were provided for this extract.  
No human study was provided which evaluated the effect of pumpkin seeds as such on the claimed 
effect.  
The Panel considers that the food, Cucurbita pepo L. (pumpkin) seeds and seed extracts, which is the 
subject of the claims, is not sufficiently characterised in relation to the claimed effects considered in 
this section. 
The Panel concludes that a cause and effect relationship cannot be established between the 
consumption of Cucurbita pepo L. (pumpkin) seeds and seed extracts and the claimed effects 
considered in this section. 
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CONCLUSIONS  
On the basis of the data presented, the Panel concludes that:  
 The following foods/food constituents are not sufficiently characterised, or are not sufficiently 
characterised in relation to the claimed effects: 
 Dairy products related to: weight management and maintenance of tooth mineralisation 
(ID 1140, 1141, 1191).  
 Raw or processed food products of animal origin, plus bread and panification products related 
to: maintenance of blood cholesterol concentrations and blood glucose control (ID 1193, 
1194). 
 Herbal yeast plasmolysate related to: physical performance and concentration (ID 1815, 
1816). 
 Apple polyphenols related to: blood glucose control (ID 2713). 
 Rye flour related to: low glycaemic index (ID 1266). 
 Tomato juice related to: blood glucose control (ID 1202).  
 Whey protein and alphalactalbumin related to: immune defence against pathogens, cognitive 
function, mood and blood pressure (ID 424, 430, 432, 725, 1433).  
 “Brocco shoots”, “broccoli sprout powder” and “Brassica oleracea var. italica (broccoli)” 
related to: protection of cells and molecules, including cells of the immune system, from 
oxidative damage (ID 1362, 1481, 2844, 2845). 
 Honey related to: protection of cells and molecules from oxidative damage, defence against 
pathogens, and maintenance of blood cholesterol concentrations (ID 1159, 1160, 1318, 4678, 
4679). 
 Cucurbita pepo L. (pumpkin) seeds and seed extracts related to: maintenance of normal 
prostate size and normal urination (ID 2029, 2365). 
 A cause and effect relationship cannot be established between the foods/food constituents which 
are the subject of this opinion and the claimed effects. 
DOCUMENTATION PROVIDED TO EFSA 
Health claims pursuant to Article 13 of Regulation (EC) No 1924/2006 (No: EFSA-Q-2008-1211, 
EFSA-Q-2008-1217, EFSA-Q-2008-1219, EFSA-Q-2008-1512, EFSA-Q-2008-1879, EFSA-Q-2008-
1880, EFSA-Q-2008-1898, EFSA-Q-2008-1899, EFSA-Q-2008-1930, EFSA-Q-2008-1932, EFSA-Q-
2008-1933, EFSA-Q-2008-1941, EFSA-Q-2008-2004, EFSA-Q-2008-2055, EFSA-Q-2008-2099, 
EFSA-Q-2008-2170, EFSA-Q-2008-2218, EFSA-Q-2008-2548, EFSA-Q-2008-2549, EFSA-Q-2008-
2762, EFSA-Q-2008-3098, EFSA-Q-2008-3446, EFSA-Q-2008-3577, EFSA-Q-2008-3578, EFSA-Q-
2010-00631, EFSA-Q-2010-00632). The scientific substantiation is based on the information provided 
by the Member States in the consolidated list of Article 13 health claims and references that EFSA 
has received from Member States or directly from stakeholders. 
The full list of supporting references as provided to EFSA is available on: 
http://www.efsa.europa.eu/panels/nda/claims/article13.htm. 
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APPENDICES 
APPENDIX A 
BACKGROUND AND TERMS OF REFERENCE AS PROVIDED BY THE EUROPEAN COMMISSION 
The Regulation 1924/2006 on nutrition and health claims made on foods
8
 (hereinafter "the 
Regulation") entered into force on 19th January 2007. 
Article 13 of the Regulation foresees that the Commission shall adopt a Community list of permitted 
health claims other than those referring to the reduction of disease risk and to children's development 
and health. This Community list shall be adopted through the Regulatory Committee procedure and 
following consultation of the European Food Safety Authority (EFSA). 
Health claims are defined as "any claim that states, suggests or implies that a relationship exists 
between a food category, a food or one of its constituents and health".  
In accordance with Article 13 (1) health claims other than those referring to the reduction of disease 
risk and to children's development and health are health claims describing or referring to:  
a) the role of a nutrient or other substance in growth, development and the functions of the 
body; or 
b) psychological and behavioural functions; or 
c) without prejudice to Directive 96/8/EC, slimming or weight-control or a reduction in the 
sense of hunger or an increase in the sense of satiety or to the reduction of the available 
energy from the diet. 
To be included in the Community list of permitted health claims, the claims shall be:  
(i) based on generally accepted scientific evidence; and 
(ii) well understood by the average consumer. 
Member States provided the Commission with lists of claims as referred to in Article 13 (1) by 31 
January 2008 accompanied by the conditions applying to them and by references to the relevant 
scientific justification. These lists have been consolidated into the list which forms the basis for the 
EFSA consultation in accordance with Article 13 (3).  
ISSUES THAT NEED TO BE CONSIDERED 
IMPORTANCE AND PERTINENCE OF THE FOOD
9
  
Foods are commonly involved in many different functions
10 
of the body, and for one single food many 
health claims may therefore be scientifically true. Therefore, the relative importance of food e.g. 
nutrients in relation to other nutrients for the expressed beneficial effect should be considered: for 
functions affected by a large number of dietary factors it should be considered whether a reference to 
a single food is scientifically pertinent.  
                                                     
8  OJ  L12, 18/01/2007 
9  The term 'food' when used in this Terms of Reference refers to a food constituent, the food or the food category.  
10  The term 'function' when used in this Terms of Reference refers to health claims in Article 13(1)(a), (b) and (c).   
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It should also be considered if the information on the characteristics of the food contains aspects 
pertinent to the beneficial effect.  
SUBSTANTIATION OF CLAIMS BY GENERALLY ACCEPTABLE SCIENTIFIC EVIDENCE 
Scientific substantiation is the main aspect to be taken into account to authorise health claims. Claims 
should be scientifically substantiated by taking into account the totality of the available scientific 
data, and by weighing the evidence, and shall demonstrate the extent to which: 
(a) the claimed effect of the food is beneficial for human health, 
(b) a cause and effect relationship is established between consumption of the food and the 
claimed effect in humans (such as: the strength, consistency, specificity, dose-
response, and biological plausibility of the relationship), 
(c) the quantity of the food and pattern of consumption required to obtain the claimed 
effect could reasonably be achieved as part of a balanced diet, 
(d) the specific study group(s) in which the evidence was obtained is representative of the 
target population for which the claim is intended. 
EFSA has mentioned in its scientific and technical guidance for the preparation and presentation of 
the application for authorisation of health claims consistent criteria for the potential sources of 
scientific data. Such sources may not be available for all health claims. Nevertheless it will be 
relevant and important that EFSA comments on the availability and quality of such data in order to 
allow the regulator to judge and make a risk management decision about the acceptability of health 
claims included in the submitted list. 
The scientific evidence about the role of a food on a nutritional or physiological function is not 
enough to justify the claim. The beneficial effect of the dietary intake has also to be demonstrated. 
Moreover, the beneficial effect should be significant i.e. satisfactorily demonstrate to beneficially 
affect identified functions in the body in a way which is relevant to health. Although an appreciation 
of the beneficial effect in relation to the nutritional status of the European population may be of 
interest, the presence or absence of the actual need for a nutrient or other substance with nutritional or 
physiological effect for that population should not, however, condition such considerations. 
Different types of effects can be claimed. Claims referring to the maintenance of a function may be 
distinct from claims referring to the improvement of a function. EFSA may wish to comment whether 
such different claims comply with the criteria laid down in the Regulation. 
WORDING OF HEALTH CLAIMS 
Scientific substantiation of health claims is the main aspect on which EFSA's opinion is requested. 
However, the wording of health claims should also be commented by EFSA in its opinion. 
There is potentially a plethora of expressions that may be used to convey the relationship between the 
food and the function. This may be due to commercial practices, consumer perception and linguistic 
or cultural differences across the EU. Nevertheless, the wording used to make health claims should be 
truthful, clear, reliable and useful to the consumer in choosing a healthy diet. 
In addition to fulfilling the general principles and conditions of the Regulation laid down in Article 3 
and 5, Article 13(1)(a) stipulates that health claims shall describe or refer to "the role of a nutrient or 
other substance in growth, development and the functions of the body". Therefore, the requirement to 
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describe or refer to the 'role' of a nutrient or substance in growth, development and the functions of 
the body should be carefully considered. 
The specificity of the wording is very important. Health claims such as "Substance X supports the 
function of the joints" may not sufficiently do so, whereas a claim such as "Substance X helps 
maintain the flexibility of the joints" would. In the first example of a claim it is unclear which of the 
various functions of the joints is described or referred to contrary to the latter example which 
specifies this by using the word "flexibility". 
The clarity of the wording is very important. The guiding principle should be that the description or 
reference to the role of the nutrient or other substance shall be clear and unambiguous and therefore 
be specified to the extent possible i.e. descriptive words/ terms which can have multiple meanings 
should be avoided. To this end, wordings like "strengthens your natural defences" or "contain 
antioxidants" should be considered as well as "may" or "might" as opposed to words like 
"contributes", "aids" or "helps".  
In addition, for functions affected by a large number of dietary factors it should be considered 
whether wordings such as "indispensable", "necessary", "essential" and "important" reflects the 
strength of the scientific evidence. 
Similar alternative wordings as mentioned above are used for claims relating to different relationships 
between the various foods and health. It is not the intention of the regulator to adopt a detailed and 
rigid list of claims where all possible wordings for the different claims are approved. Therefore, it is 
not required that EFSA comments on each individual wording for each claim unless the wording is 
strictly pertinent to a specific claim. It would be appreciated though that EFSA may consider and 
comment generally on such elements relating to wording to ensure the compliance with the criteria 
laid down in the Regulation. 
In doing so the explanation provided for in recital 16 of the Regulation on the notion of the average 
consumer should be recalled. In addition, such assessment should take into account the particular 
perspective and/or knowledge in the target group of the claim, if such is indicated or implied. 
TERMS OF REFERENCE 
HEALTH CLAIMS OTHER THAN THOSE REFERRING TO THE REDUCTION OF DISEASE RISK AND TO 
CHILDREN'S DEVELOPMENT AND HEALTH 
EFSA should in particular consider, and provide advice on the following aspects:  
 Whether adequate information is provided on the characteristics of the food pertinent to the 
beneficial effect. 
 Whether the beneficial effect of the food on the function is substantiated by generally 
accepted scientific evidence by taking into account the totality of the available scientific data, 
and by weighing the evidence. In this context EFSA is invited to comment on the nature and 
quality of the totality of the evidence provided according to consistent criteria. 
 The specific importance of the food for the claimed effect. For functions affected by a large 
number of dietary factors whether a reference to a single food is scientifically pertinent.  
In addition, EFSA should consider the claimed effect on the function, and provide advice on the 
extent to which: 
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 the claimed effect of the food in the identified function is beneficial. 
 a cause and effect relationship has been established between consumption of the food and the 
claimed effect in humans and whether the magnitude of the effect is related to the quantity 
consumed. 
 where appropriate, the effect on the function is significant in relation to the quantity of the 
food proposed to be consumed and if this quantity could reasonably be consumed as part of a 
balanced diet.  
 the specific study group(s) in which the evidence was obtained is representative of the target 
population for which the claim is intended. 
 the wordings used to express the claimed effect reflect the scientific evidence and complies 
with the criteria laid down in the Regulation.  
When considering these elements EFSA should also provide advice, when appropriate: 
 on the appropriate application of Article 10 (2) (c) and (d) in the Regulation, which provides 
for additional labelling requirements addressed to persons who should avoid using the food; 
and/or warnings for products that are likely to present a health risk if consumed to excess. 
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APPENDIX B 
EFSA DISCLAIMER 
The present opinion does not constitute, and cannot be construed as, an authorisation to the marketing 
of the food/food constituent, a positive assessment of its safety, nor a decision on whether the 
food/food constituent is, or is not, classified as foodstuffs. It should be noted that such an assessment 
is not foreseen in the framework of Regulation (EC) No 1924/2006. 
It should also be highlighted that the scope, the proposed wordings of the claims and the conditions of 
use as proposed in the Consolidated List may be subject to changes, pending the outcome of the 
authorisation procedure foreseen in Article 13(3) of Regulation (EC) No 1924/2006. 
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APPENDIX C 
Table 1. Main entry health claims related to not sufficiently characterised foods/food constituents, 
including conditions of use from similar claims, as proposed in the Consolidated List. 
ID Food or Food constituent Health Relationship Proposed wording 
424 Whey protein Supports a healthy immune 
system 
Whey protein helps athletes 
maintain a healthy immune 
system by increasing the levels 
of glutathione in the body. 
Glutathione is an antioxidant 
required for a healthy immune 
system and exercise and 
resistance training may reduce 
glutathione levels. 
 Conditions of use 
- Must meet minimum requirements for use of the claim "source of [name of vitamin/s] and/or 
[name of mineral/s], source of protein etc (delete as appropriate)" as per Annex to 
Regulation 1924/2006. 
- 20 grams per day Must meet minimum requirements for use of the claim "source of protein" 
as per Annex to Regulation 1924/2006. 
ID Food or Food constituent Health Relationship Proposed wording 
430 Whey protein Cognitive function 
Clarifications provided: 
Cognitive Health - Whey 
protein rich in alpha 
lactalbumin increases 
availability of plasma 
tryptophan, a precursor to 
brain serotonin, which 
maintains optimal cognitive 
function   
Whey protein improves 
cognitive performance 
 Conditions of use 
Must meet minimum requirements for use of the claim "source of [name of vitamin/s] and/or 
[name of mineral/s], source of protein etc (delete as appropriate)" as per Annex to Regulation 
1924/2006. 
ID Food or Food constituent Health Relationship Proposed wording 
432 Whey protein Stress and mental health 
Clarifications provided: 
Stress and mental health - 
Whey protein rich in alpha 
lactalbumin leads to higher 
tryptophan availability 
resulting in increased brain 
serotonin synthesis which 
supports mental health and 
improves mood, particularly 
in stress vulnerable people 
Whey protein enhances mood 
and mental well-being 
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 Conditions of use 
Must meet minimum requirements for use of the claim "source of [name of vitamin/s] and/or 
[name of mineral/s], source of protein etc (delete as appropriate)" as per Annex to Regulation 
1924/2006 
ID Food or Food constituent Health Relationship Proposed wording 
725 Whey protein peptides  Maintaining vascular health 
Clarification provided 
Whey proteins are a source 
of bioactive peptides that 
can aid/support healthy 
blood circulation. 
Helps maintain a healthy 
vascular system 
 Conditions of use 
Must meet minimum requirements for use of the claim "source of protein" as per Annex to 
Regulation 1924/2006. 
ID Food or Food component Health Relationship Proposed wording 
1140 Dairy (low fat dairy) 
*Dairy refers to cow’s milk, 
yogurt and cheese 
Clarification provided 
“Low fat dairy” - studies refer 
to low fat milk and low fat 
dairy products (yogurt) for 
which low fat milk is the 
principle ingredient.  
Low fat milk and low fat dairy 
foods (yogurt) will be a source 
of calcium as per annex to 
regulation 1924/2006.  
The nutritional composition of 
low fat milk and low fat dairy 
products (yogurt) should reflect 
that stated in food composition 
tables. 
Weight loss  
Fat loss 
Weight maintenance 
Dairy in an energy restricted 
diet helps weight loss. 
Consuming dairy foods, as 
part of your weight loss diet, 
will help weight loss.  
Consuming dairy foods, as 
part of your weight loss diet, 
will help weight maintenance. 
 Conditions of use 
kalorienreduzierte Diät; 
-low fat, As part of a healthy balanced diet and lifestyle 
ID Food or Food component Health Relationship Proposed wording 
1141 (Cow’s) Milk 
And dairy products for which 
milk is the principle ingredient 
and no sugar has been added – 
e.g. yogurt, cheese. 
Clarification provided 
(Cow's) Milk And dairy 
Dental Health (Cow’s) Milk products help 
support dental health. 
(Cow’s) Milk helps support 
the normal and healthy 
development of teeth. 
(Cow’s) Milk contributes to 
dental health. 
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products for which milk is the 
principle ingredient and no 
sugar has been added – e.g. 
yogurt, cheese (Hard). 
Milk and dairy foods will be a 
source of calcium as per annex 
to regulation 1924/2006. 
Dairy foods are consumed as 
part of a healthy and balanced 
diet.  
The nutritional composition of 
milk and dairy foods should 
reflect that stated in food 
composition tables. 
(Cow’s) Milk helps maintain 
healthy teeth 
(Cow’s) Milk helps keep teeth 
healthy. 
 Conditions of use 
(Cow’s) Milk (to which no sugar has been added) 
ID Food or Food constituent Health Relationship Proposed wording 
1159 Honey (as defined by The 
Honey Regulations 2003 (as 
amended)). 
Antioxidant properties Plus 
Antimicrobial properties. 
Helps maintain your natural 
defences. 
Honey antioxidants contribute 
to the total antioxidative 
capacity of the body. 
Honey contains 
naturally-occurring 
antioxidants. 
Honey helps to support the 
digestion with a natural 
antimicrobial action. 
 Honey helps contribute to the 
natural defences of the body. 
Honey helps to support the 
digestion. 
Honey polyphenols help 
ensure our antioxidant 
capacity. 
Honey has a natural 
antimicrobial action. 
 Conditions of use 
- Internal use: 20-30 g per day.  
- 15g per day. 
- Honey (the required amount is not indicated). Heating honey to a temperature of over +60 
degrees for more than 10 minutes reduces its enzymes by approximately 50%. 
ID Food or Food constituent Health Relationship Proposed wording 
1160 Honey. Digestive health through 
presence of 
Helps support and maintain a 
healthy digestive system. 
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fructooliggosaccharides and 
antioxidant phytochemicals. 
Clarification provided 
Helps maintain healthy 
skin/epithelial layer of the 
digestive tract and thus helps 
to maintain a healthy 
digestive tract. 
Increases growth of 
probiotic bacteria. 
Increases growth of 
Lactobacillus spp. 
 
 Conditions of use 
- 12.5g half an hour before food 4 times daily. Advisory Statement: Honey contains natural 
sugars. 
- Honey (the required amount is not indicated). Heating honey to a temperature of over +60 
degrees for more than 10 minutes reduces its enzymes by approximately 50%. 
ID Food or Food component Health Relationship Proposed wording 
1191 Fat free dairy products with 
reduced sugars or without 
added sugars  
Clarification provided 
Fat-free (1) dairy products (2) 
with no added sugars or with 
reduced sugars (3) (4).  
(1): fat free, i.e. containing less 
than 0.5 g of fat per 100 g of 
product as defined per 
Regulation EC N°1924/2006 
on Nutrition and  
Health Claims made on foods. 
(2): as defined in the 
COUNCIL REGULATION 
(EC) No 1234/2007 of 22 
October 2007  
establishing a common 
organisation of agricultural 
markets and on specific 
provisions for certain 
agricultural products. 
Dairy products, which would 
include but not be limited to 
the following: milks, fermented 
milks (including yoghurts), 
fresh cheeses (including "petits 
suisses"). 
Body weight control 1 - Main wording 
In French: 
  - Les produits laitiers à 0% de 
matière grasse et à teneur 
réduite en sucres (ou sans 
sucres ajoutés) aident à 
contrôler le poids corporel 
dans le cadre d’une 
alimentation équilibrée. 
In English : 
  - Fat free dairy products with 
reduced sugars or without 
added sugars help control body 
weight as part of a balanced 
diet. 
 2 - Other examples of 
wordings 
In French : 
      - aide à maintenir le poids 
corporel 
      - aide à garder la ligne 
      - partenaire nutritionnel de 
votre ligne 
In English : 
      - help maintain body 
weight 
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(3):  with no added sugars or 
reduced in sugar as defined per 
Regulation EC N°1924/2006 
on Nutrition and Health Claims 
made on foods, i.e. containing 
at least 30% less sugars than a 
standard product. 
(4): at least one serving of a 
fat-free dairy product with no 
added sugars or with reduced 
sugars per day instead of the 
corresponding standard dairy 
product, as part of a varied and 
balanced diet and a healthy 
lifestyle. 
      - help keep your figure 
      - nutritional partner of your 
figure  
 Conditions of use 
▪ dairy products; ▪ and fat free(1); ▪ and with reduced sugars or without added sugars(1); ▪ As 
part of a daily intake by adults; (1)as defined in the Regulation (EC) No 1924/2006 of the 
European Parliament and of the Council of 20 December 2006 on nutrition and health claims 
made on foods (Annex I) 
ID Food or Food component Health Relationship Proposed wording 
1193 Raw or processed food 
products of animal origin, plus 
bread and panification  
products  (cow’s, goat’s and 
ewe’s  milk and related 
products ( milk, cream, butter, 
cheese, yoghurt, fresh dairy 
products); hen’s and quail’s 
eggs; beef’s, veal’s and lamb’s 
meat; poultry’s meat (chicken, 
pigeon, turkey); rabbit’s meat; 
pork’s meat and related 
products ( ham, pork-
butchery), ), bread and 
panification products. 
Specifications for each group 
of products is given in annexes 
of the dossier Tradilin quoted 
A4 above ), intended for the 
general population and  whose 
elaboration strictly respect  
Tradilin specifications and 
which consequently have an 
improved lipid quality, 
including an enhanced omega 3 
content, relatively to standard 
equivalent product.  
Quality of dietary lipids and 
blood lipid profile 
* The Tradilin  network makes 
it possible to obtain products 
which fit into a diet naturally 
rich in omega 3, which favors 
the balance/a good balance  of 
blood lipids 
La filière Bleu-Blanc-Coeur / 
Tradilin permet d’obtenir des 
produits  qui s’intègrent dans 
une alimentation naturellement 
riche en oméga 3, qui favorise 
l’équilibre des lipides sanguins  
* A diet which includes 
products from the Tradilin 
network favours a good 
balance of blood lipids.  
S’alimenter avec des produits, 
issus de la filière Tradilin 
favorise l’équilibre des lipides 
sanguins 
* This product participates/ 
contributes to improve the 
balance of blood lipids. 
Ce produit contribue/participe 
à l’amélioration de l’équilibre 
des lipides sanguins 
* This product, from de 
Tradilin network fits in a diet 
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naturally increased in Omega 
3, which favors the balance of 
blood lipids 
Ce produit, issu de la filière 
Tradilin s’intègre dans une 
alimentation naturellement 
riche en Oméga 3, qui favorise 
l’équilibre des lipides sanguins  
 Conditions of use 
Using the product in substitution of its standard equivalent and in combination with other 
Tradilin animal products. Such diet should be kept for at least one month.  
 No clarification provided by Member States 
ID Food or Food component Health Relationship Proposed wording 
1194 Raw or processed food 
products of animal origin, plus 
bread and panification  
products  (cow’s, goat’s and 
ewe’s  milk and related 
products ( milk, cream, butter, 
cheese, yoghurt, fresh dairy 
products); hen’s and quail’s 
eggs; beef’s, veal’s and lamb’s 
meat; poultry’s meat (chicken, 
pigeon, turkey); rabbit’s meat; 
pork’s meat and related 
products ( ham, pork-
butchery), ), bread and 
panification products. 
Specifications for each group 
of products is given in annexes 
of the dossier Tradilin quoted 
A4 above ), intended for the 
general population and  whose 
elaboration strictly respect  
Tradilin specifications and 
which consequently have an 
improved lipid quality, 
including an enhanced omega 3 
content, relatively to standard 
equivalent product.  
Quality of dietary lipids and 
nutrient (carbohydrates) 
metabolism 
* The Tradilin  network makes 
it possible to obtain products 
which fit into a diet naturally 
rich in omega 3 which 
participates  to 
improve/decrease carbohydrate 
metabolic disorders 
La filière Tradilin permet 
d’obtenir des produits qui  
s’intègrent dans une 
alimentation riche en Oméga 3 
qui participe diminuer les 
désordres du métabolisme des 
carbohydrates  
* The Tradilin  network makes 
it possible to obtain products 
which fit into a diet naturally 
rich in omega 3 which 
participates  in the control of 
parameters of the metabolic 
syndrome 
La filière Tradilin permet 
d’obtenir des produits qui  
s’intègrent dans une 
alimentation riche en Oméga 3 
qui participe au contrôle des 
paramètres du syndrome 
métabolique 
* This product 
participates/contributes/helps  
to regulate carbohydrate 
metabolism 
Ce produit participe à la 
régulation du métabolisme 
glucidique  
* This product, from the 
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Tradilin network,  helps  to 
better to regulate carbohydrate 
metabolism/ control the 
parameters on the metabolic 
syndrome 
Ce produit, issu de la filière 
Tradilin, s’intègre dans une 
alimentation riche en Oméga 3 
qui participe à diminuer les 
désordres du métabolisme des 
carbohydrates/à contrôler les 
paramètres du syndrome 
métabolique 
 Conditions of use 
Using the product in substitution of its standard equivalent and in combination with other 
Tradilin animal products. Such diet should be kept for at least one month.  
 No clarification provided by Member States 
ID Food or Food constituent Health Relationship Proposed wording 
1202 Tomato juice. Cardiovascular System. Tomato juice has a positive 
Influence on blood sugar level. 
 Conditions of use 
- 250 ml per day over 3 weeks. 
ID Food or Food constituent Health Relationship Proposed wording 
1266 Rye flour Rye flour's low glycaemic 
index. 
Rukkijahu iseloomustab madal 
glükeemiline indeks. 
Clarification provided 
Rye flower is characterised by 
low glycaemic index. 
 Conditions of use 
Rukkijahust valmistatud leib. 
 Comments from Member States 
Rye flower is characterised by low glycaemic index. 
ID Food or Food constituent Health Relationship Proposed wording 
1318 Honey. Antibacterial and antifungal 
properties. 
Target Group:  For children 
and adults older than three 
years old. 
Excluded Group : Nobody 
(only person who are 
allergic). 
Clarification provided 
Contribute to the total 
antioxidant capacity of the 
body/Stimulates the body. 
Flavonoids contained within 
the honey contribute to the 
microbial balance in the body 
organs and tissues. 
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 Conditions of use 
- 20-30 g per day. Safe limits of use: No limits. Warning : Not for people who are allergic to 
the honey - No interaction to the association of honey with the administration of traditional 
therapeutic substance, either natural or synthetic, has been observed. 
- Miel+huile 3x1-2 pastilles/jour. 
 Comments from Member States 
LU: Aggree with GR proposal. 20-30 g per day. Safe limits of use: No limits. Warning : Not for 
people who are allergic to the honey - No interaction to the association of honey with the 
administration of traditional therapeutic substance, either natural or synthetic, has been obser. 
ID Food or Food constituent Health Relationship Proposed wording 
1362 Name of Food product: Brocco 
Shoots. 
Description of food in terms of 
food legislation categories: 
food not covered by specific 
food legislation. 
Was food on Irish market 
before 1st July 2007: Yes. 
Health benefits of food: 
Naturally boosts your 
immune system. 
Do benefits relate to a 
disease risk factor: No. 
Target group: All of the 
general population including 
children and adults. 
Clarification provided 
Health benefits of food: 
natural source of 
sulforaphane which may 
help prevent cell damage 
Do benefits relate to a 
disease risk factor: No 
Target group: All of the 
general population including 
children and adults 
Exact wording of claim as it 
appears on product: Brocco 
Shoots naturally boost your 
immune system. 
Is claim a picture: No. 
 Conditions of use 
- Weight of average daily food serving: 20 gram(s). 
- Daily amount to be consumed to produce claimed effect: 20 gram(s). 
- Number of food portions this equates to in everyday food portions: 1. 
- Are there factors that could interfere with bioavailability: No 
- Length of time after consumption for claimed effect to become apparent: It is apparent after 
a period of regular use.  
- Number of days: 30. 
- Is there a limit to the amount of food which should be consumed in order to avoid adverse 
health effects: No. 
- Where applicable outline nutritional composition (g per 100g) of food: Total Fat: 1.69, 
Saturated Fat: .49, Trans Fat: .00, Sugar: 1.36, Salt: .00, Sodium: .02 
 Comments from Member States 
Clarification/further information/alternative wording which was provided by the FBO has been 
included. The FBO includes a document (attached and identifed by claim number- additional 
information) with additional information on the health relationship.  
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ID Food or Food constituent Health Relationship Proposed wording 
1433 a-Lactalbumin Functions in 
neurotransmitter formation 
Clarification provided 
Cognitive function: 
Increases alertness and 
attnetion span and is 
anxiolytic 
a-Lactalbumin increases 
cognitive function 
 Conditions of use 
At least 12 g per day 
ID Food or Food constituent Health Relationship Proposed wording 
1481 Broccoli Sprout Powder. Antioxidant properties. Helps to protect the bodies 
cells against oxidative stress. 
 Conditions of use 
- 1g per day. 
ID Food or Food constituent Health Relationship Proposed wording 
1815 Herbal yeast plasmolycate 
(saccharomyces cerevisiae) 
Physical performance and 
condition 
Clarification provided 
Herbal yeast plasmolysate 
improves physical and 
mental performances, 
increases the concentration, 
helps against fatigue and 
nervousness and restores 
vitality. 
Improves performance 
 Conditions of use 
- Herbal yeast preparation with 2.7-4.5 g of herbal yeast plasmolycate (saccharomyces 
cerevisiae) in the daily dose 
ID Food or Food constituent Health Relationship Proposed wording 
1816 Herbal yeast plasmolycate 
(saccharomyces cerevisiae) 
Mental state and 
performance 
Adds vigour and activity. 
Reduces feeling of tiredness. 
Improves concentration. 
 Conditions of use 
- Herbal yeast preparation with 2.7-4.5 g of herbal yeast plasmolycate (saccharomyces 
cerevisiae) in the daily dose. 
- 5ml to be taken three times daily 
ID Food or Food constituent Health Relationship Proposed wording 
2029 Cucurbita pepo (Common 
Name: Pumpkin). 
Health of lower urinary tract. 
Clarification provided 
Health of lower urinary tract/ 
Maintenance of good bladder 
function and urinary 
flow/good for normal prostate 
function. 
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Supports/helps to maintain 
good bladder and prostate 
function. Maintains normal 
urinary flow and reduces 
frequency and urge of 
urination in men. Helps to 
maintain good urinary flow. 
Good for normal bladder 
function. Good for normal 
urinary flow. Helps to 
reduce need for continuous 
need to urinate. Helps to 
reduce need for repeated 
need to urinate. 
 Conditions of use 
- nasiona/ równowartość 190- 600 mg oleju lub 30-60 g pestek na dzień.  
- 400 mg pro Tag.  
- Kürbiskernextrakt 7:1600 mg pro Tag.  
- 400mg Kürbiskonzentrat, 2.222mg Kürskerne (als Extrakt).  
- 2 EL = 20 g täglich. 
- 500 mg Nahrungsergänzung.  
- <60 bis 120mg β-Sterole 3x täglich––Erwachsene.  
- Kerne/Männer und Frauen–Tagesdosis Extrakt: entpsr. 400-500 mg Kürbiskernextrakt –
Tagesdosis Droge: entspr. 8-10 g Kürbsikerne ––Speziell für die Blase der Frau: –
Tagesdosis: entspr. 400 mg Kürbiskernextrakt und 30 mg Sojaextrakt (entspr. mind. 12 mg 
Isoflavone). 
- Seed / The Equivalent of 190-600 ml oil or 30-60g ground seeds per day. 
- Food supplement with 525 mg of EFLA 940 pumpkin seed extract and 100 mg of soy 
extract in the daily dose. Two tablets in which the EFLA extract is equivalent to 10.5 g of 
pumpkin seed and 0.7 g of dried soy bean. 
- Huile 4x420mg/jour. 
 Comments from Member States 
Men: health of bladder and prostate (Irritable bladder, miction complaints), Women:health of 
bladder, strenghening pelvic floor muscles, irritable bladder, stress incontinence AT. 
New scientific references: 
Sogabe H, Terado T. Open Clinical Study of Effects of Pumpkin Seed Extract/Soybean Germ 
Extract Mixture-containing Processed Food on Nocturia. Jpn J Med Pharm Sci. 2001 
Nov;46(5):727-37. 
Yanagisawa E et al. Study of Effectiveness of Mixed Processed Food Containing Cucurbita Pepo 
Seed Extract and Soybean Seed Extract on Stress Urinary Incontinence in Women. Jpn J Med 
Pharm Sci. 2003 14; No.3:313-322. 
Terado T et al. Clinical Study of mixed processed foods containing pumpkin seed extract and 
soybean germ extract on pollikiuria in night in elderly men. Jpn Med Pharm Sci. 2004 52(4):551-
561. 
Hata K et al. Effects of Pumpkin Seed Extract on urinary bladder function in anesthesized rats. 
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Jpn J Med Parm. Sci. 2005 54 (3):339-345. (Animal study) 
(Translations from Japanese into English) - FI 
ID Food or Food constituent Health Relationship Proposed wording 
2365 Pumpkin seed (Cucurbita 
pepo). 
Prostate/uri-nary tract. 
Clarification provided 
Prostate/urinary tract; health 
of urogenithal system/the 
healthy prostate function/the 
normal miction and the 
normal urinary flow. 
Contributes to maintain 
healthy prostate function. 
Conditions of use 
- 1500 mg seed, or equivalent amount of extract;(15% of the lower therapeutic dose (10000 
mg seed). 
ID Food or Food constituent Health Relationship Proposed wording 
2713 Pyrus malus (Common Name 
Apple) extract powder 
containing polyphenols. 
Blood glucose control. Can help to moderate the 
postprandial blood glucose 
level. 
Can help to decrease the blood 
glucose level. 
 Conditions of use 
- 100-250 mg per day. 
ID Food or Food constituent Health Relationship Proposed wording 
2844 Brassica olaracea var italica 
(broccoli). 
Immune system. 
Clarification provided 
Supports the immune system 
by through antioxidant 
activity. 
Helps maintain a healthy 
immune system. 
 Conditions of use 
- Broccoli seed or sprout or vegetable extract equivalent to 30mg of Glucoraphanin per day. 
ID Food or Food constituent Health Relationship Proposed wording 
2845 Brassica olaracea var italica 
(broccoli). 
Antioxidant properties and 
cell protection. 
Helps to protect cells from 
oxidation. 
Supports cell health & 
function. 
Well known source of 
antioxidants. 
Natural defense against free 
radicals. 
Helps the body to safely 
neutralize & excrete free 
radicals. 
 Conditions of use 
- Standardisierter Extrakt auf Sulforafan aus Brokkolisprossenkonzentrat–Tagesdosis 
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Brokkoli Konzentrat: 500 mg –Erwachsene.  
- Broccoli seed or sprout or vegetable extract equivalent to 30mg of Glucoraphanin per day. 
ID Food or Food constituent Health Relationship Proposed wording 
4678 Honey. Helps heart health and to 
maintain a balanced level of 
cholesterol and lipids in the 
body. 
Promotes a good heart 
functioning and a balanced 
level of blood lipids. 
 Conditions of use 
- 20 - 40 g/day or the equivalent of 1 spoonful. 
ID Food or Food constituent Health Relationship Proposed wording 
4679 Honey. Energy metabolism. Reminalizing of the organism. 
 Conditions of use 
- Usual consumption as traditional foodstuff in a normal diet / 5-10 g daily. 
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GLOSSARY AND ABREVIATIONS 
FOS  Fructooligosaccharides 
HMF  Hydroxymethyfurfural 
 
